News Search

The compound, called AEF0117, is a signaling inhibitor, which means it blocks only “a pocket” of the CB1 receptor, explains Margaret Haney, PhD, director of the Cannabis Research Laboratory.

“This is one of the very few medications that I’ve tested to directly decrease the effects of cannabis,” Margaret (Meg) Haney, PhD, the director of the cannabis research laboratory at Columbia, said. 

Dr. Nathan Ha specializes in providing mental health care to adults and older adolescents and has expertise in helping those affected by differences of race, ethnicity, gender, and sexuality.

“Our nervous system is wired to act and help us to remain safe from harm. This often assists us to help meet goals and aspirations but sometimes causes anxiety,” says Anne Marie Albano, PhD.